In 2013, Indiana bioscience companies donated $25 million, matched by a state appropriation, and announced plans to establish a center in Indianapolis that would research metabolic diseases like diabetes and heart trouble, and their connection to nutrition. But it took an $80 million gift from the Lilly Endowment and a $20 million grant from the Eli Lilly company foundation to make the proposal real three years later. The center broke ground in 2016 on a freestanding facility that is expected to bolster the Indianapolis downtown in addition to improving medical understanding.
- Reporting in the Indianapolis Star, indystar.com/story/news/2016/02/24/new-biosciences-institute-gets-100m/80794292/